The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership
- PMID: 36453848
- PMCID: PMC10393438
- DOI: 10.1093/rheumatology/keac676
The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership
Abstract
Objectives: To identify and prioritize the top 10 research questions for PsA.
Methods: The British Psoriatic Arthritis Consortium (BritPACT) formed a Priority Setting Partnership (PSP) comprising of people living with PsA, carers and clinicians, supported by the James Lind Alliance (JLA). This PSP followed the established three-stage JLA process: first, an online survey of people living with PsA, carers and clinicians to identify PsA questions, asking, 'What do you think are the most important unanswered questions in psoriatic arthritis research?' The questions were checked against existing evidence to establish 'true uncertainties' and grouped as 'indicative questions' reflecting the overarching themes. Then a second online survey ranked the 'true uncertainties' by importance. Finally, a workshop including people living with PsA and clinician stakeholders finalized the top 10 research priorities.
Results: The initial survey attracted 317 respondents (69% people living with PsA, 15% carers), with 988 questions. This generated 46 indicative questions. In the second survey, 422 respondents (78% people living with PsA, 4% carers) prioritized these. Eighteen questions were taken forward to the final online workshop. The top unanswered PsA research question was 'What is the best strategy for managing patients with psoriatic arthritis including non-drug and drug treatments?' Other top 10 priorities covered diagnosis, prognosis, outcome assessment, flares, comorbidities and other aspects of treatment (https://www.jla.nihr.ac.uk).
Conclusion: The top 10 priorities will guide PsA research and enable PsA researchers and those who fund research to know the most important questions for people living with PsA.
Keywords: James Lind Alliance; Priority Setting Partnership; consensus; psoriatic arthritis.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Figures
Comment in
-
The need to ask for directions on the winding road of psoriatic arthritis.Rheumatology (Oxford). 2023 Aug 1;62(8):2637-2638. doi: 10.1093/rheumatology/kead046. Rheumatology (Oxford). 2023. PMID: 36702466 No abstract available.
References
-
- Coates LC, Savage L, Waxman R et al. Comparison of screening questionnaires to identify psoriatic arthritis in a primary-care population: a cross-sectional study. BrJ Dermatol 2016;175:542–8. - PubMed
-
- Mease P, Gladman D, Papp K et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013;69:729–35. - PubMed
-
- Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007;157:68–73. - PubMed
-
- Husted JA, Thavaneswaran A, Chandran V et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken) 2011;63:1729–35. - PubMed
-
- Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585–92. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
